HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intracellular glutathione deficiency is associated with enhanced nuclear factor-kappaB activation in older non-insulin dependent diabetic patients.

Abstract
Diabetes mellitus may be associated with intracellular glutathione (GSH) deficiency. Since in vivo studies have shown that plasma intracellular GSH plays a key role in regulating the activation of nuclear factor kappaB (NF-kappaB), we have investigated the relationship between intracellular thiols (GSH, homocysteine, cysteine and cysteinyglycine) and NF-kappaB activity in the peripheral blood mononuclear cells (PBMC) of 63 elderly non-insulin dependent diabetes mellitus (NIDDM) patients (28 microalbuminurics and 35 normoalbuminurics) and 30 healthy age- and sex-matched subjects. In addition, we have measured plasma concentrations of these thiol compounds, serum concentrations of interleukin-6 (IL-6) and vascular cell adhesion molecule-1 (sVCAM-1), that are partly dependent on the NF-kappaB activation, as well as the serum levels of thiobarbituric acid reacting substances (TBARS), as index of lipid peroxidation. Diabetic patients with microalbuminuria (MAB) and normoalbuminuria had NF-kappaB activity 2.1- and 1.5-fold greater, respectively, than the control group. As compared to normoalbuminuric patients, patients with MAB had significantly higher levels of glycemia, plasma homocysteine, and serum concentrations of TBARS, IL-6 and sVCAM-1 (in all cases, p < 0.01), and significantly lower GSH content in the PBMC (p < 0.05). The intracellular GSH in PBMC correlated with NF-kappaB activation (r = -0.82; p < 0.0001), serum TBARS (r = -0.60; p < 0.001), and with fasting glycemia (r = -0.56; p < 0.001) in patients with MAB, whereas a weaker association between GSH levels in PBMC and NF-kappaB activation (r = -0.504, p < 0.001) was seen in patients without MAB. These results suggest that the decrease of intracellular GSH content in elderly NIDDM patients with MAB is strongly associated with enhanced NF-kappaB activation, which could contribute to the development of increased glomerular capillary permeability and its rapid progression.
AuthorsF Arnalich, A Hernanz, D López-Maderuelo, M De la Fuente, F M Arnalich, E Andres-Mateos, C Fernández-Capitán, C Montiel
JournalFree radical research (Free Radic Res) Vol. 35 Issue 6 Pg. 873-84 (Dec 2001) ISSN: 1071-5762 [Print] England
PMID11811538 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-6
  • NF-kappa B
  • Sulfhydryl Compounds
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • DNA
  • Glutathione
  • Methotrexate
Topics
  • Age Factors
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (blood)
  • Cyclophosphamide (blood)
  • DNA (metabolism)
  • Diabetes Mellitus, Type 2 (blood, metabolism)
  • Doxorubicin (blood)
  • Electrophoretic Mobility Shift Assay
  • Etoposide (blood)
  • Female
  • Glutathione (deficiency)
  • Humans
  • Interleukin-6 (blood)
  • Male
  • Methotrexate (blood)
  • NF-kappa B (blood, metabolism)
  • Sulfhydryl Compounds (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: